|
EP0113245B1
(en)
*
|
1982-12-29 |
1989-03-15 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Cephalosporin derivatives
|
|
CA2031927A1
(en)
|
1989-12-27 |
1991-06-28 |
Imperial Oil Limited |
Method for improving the activity maintenance of a plasma initiator
|
|
WO1991009598A1
(en)
|
1990-01-05 |
1991-07-11 |
Pfizer Inc. |
Azaoxindole derivatives
|
|
US5112820A
(en)
*
|
1990-03-05 |
1992-05-12 |
Sterling Drug Inc. |
Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
|
|
GB9109246D0
(en)
|
1991-04-30 |
1991-06-19 |
Ici Plc |
Nitrogen derivatives
|
|
DE4129603A1
(de)
|
1991-09-06 |
1993-03-11 |
Thomae Gmbh Dr K |
Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
TW263504B
(cg-RX-API-DMAC7.html)
|
1991-10-03 |
1995-11-21 |
Pfizer |
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
US5468757A
(en)
|
1994-01-31 |
1995-11-21 |
Eli Lilly And Company |
6-azaindole thromboxane synthase inhibitors
|
|
CO4340691A1
(es)
|
1994-02-18 |
1996-07-30 |
Boehringer Ingelheim Pharma |
2-HETEROARIL-5,11-DIHIDRO-6H-DIPIRIDO(3,2-b:2´, 3´ -e) (1, 4)-DIAZEPINAS .
|
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
US5589482A
(en)
|
1994-12-14 |
1996-12-31 |
Pfizer Inc. |
Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
|
|
JPH0920779A
(ja)
|
1995-05-01 |
1997-01-21 |
Japan Tobacco Inc |
縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
|
|
GB9610811D0
(en)
|
1996-05-23 |
1996-07-31 |
Pharmacia Spa |
Combinatorial solid phase synthesis of a library of indole derivatives
|
|
US6696448B2
(en)
|
1996-06-05 |
2004-02-24 |
Sugen, Inc. |
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
|
|
WO1998006703A1
(en)
|
1996-08-14 |
1998-02-19 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as mcp-1 antagonists
|
|
TWI242011B
(en)
|
1997-03-31 |
2005-10-21 |
Eisai Co Ltd |
1,4-substituted cyclic amine derivatives
|
|
JP2002511852A
(ja)
|
1997-05-07 |
2002-04-16 |
スージェン・インコーポレーテッド |
蛋白質キナーゼ活性の調節剤としての２−インドリノン誘導体
|
|
EP0931872B1
(de)
|
1998-01-23 |
2003-04-09 |
Voith Paper Patent GmbH |
Verfahren zur Entfernung von feinen Verunreinigungen aus einer Faserstoffsuspension
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
JP2002523455A
(ja)
|
1998-08-31 |
2002-07-30 |
スージェン・インコーポレーテッド |
蛋白質キナーゼ活性の調節剤としての幾何学的に制限された２−インドリノン誘導体
|
|
GB9904995D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Substituted aza-oxindole derivatives
|
|
JP2002538206A
(ja)
|
1999-03-10 |
2002-11-12 |
メルク エンド カムパニー インコーポレーテッド |
性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
|
|
CA2367121A1
(en)
|
1999-03-10 |
2000-09-14 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
JP2002538204A
(ja)
|
1999-03-10 |
2002-11-12 |
メルク エンド カムパニー インコーポレーテッド |
性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
|
|
EP1161431A4
(en)
|
1999-03-10 |
2002-04-24 |
Merck & Co Inc |
6-AZAINDOL COMPOUNDS AS AN ANTAGONISTS OF THE GONADOTROPIN RELEASE HORMONES
|
|
EP1171125A1
(en)
|
1999-03-10 |
2002-01-16 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
AU3514200A
(en)
|
1999-03-10 |
2000-09-28 |
Merck & Co., Inc. |
6-azaindole compounds as antagonists of gonadotropin releasing hormone
|
|
CA2390948A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
WO2000075145A1
(en)
|
1999-06-03 |
2000-12-14 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
WO2001058869A2
(en)
|
2000-02-11 |
2001-08-16 |
Bristol-Myers Squibb Company |
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
|
|
US20020061892A1
(en)
|
2000-02-22 |
2002-05-23 |
Tao Wang |
Antiviral azaindole derivatives
|
|
EP1132389A1
(en)
|
2000-03-06 |
2001-09-12 |
Vernalis Research Limited |
New aza-indolyl derivatives for the treatment of obesity
|
|
CA2407677A1
(en)
|
2000-04-28 |
2002-10-28 |
Baxter Healthcare Sa |
2-acyl indol derivatives and their use as anti-tumour agents
|
|
AR028385A1
(es)
|
2000-04-28 |
2003-05-07 |
Acadia Pharm Inc |
Agonistas muscarinicos
|
|
US7332494B2
(en)
|
2000-08-14 |
2008-02-19 |
Janssen Pharmaceutica, N.V. |
Method for treating allergies using substituted pyrazoles
|
|
HK1052705B
(en)
|
2000-08-14 |
2006-09-29 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrazole
|
|
US7342016B2
(en)
|
2000-08-30 |
2008-03-11 |
Schering Corporation |
Farnesyl protein transferase inhibitors as antitumor agents
|
|
US6369032B1
(en)
|
2000-09-06 |
2002-04-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for treating allergies
|
|
PT1315492E
(pt)
|
2000-09-06 |
2008-10-01 |
Ortho Mcneil Pharm Inc |
Utilização de pirazoles substituídos para o tratamento de alergias
|
|
AU2002211828A1
(en)
|
2000-10-02 |
2002-04-15 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
IL156776A0
(en)
|
2001-01-17 |
2004-02-08 |
Amura Therapeutics Ltd |
Inhibitors of cruzipain and other cysteine proteases
|
|
US20030207910A1
(en)
|
2001-02-02 |
2003-11-06 |
Tao Wang |
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
|
|
EP1363705B9
(en)
|
2001-02-02 |
2012-11-07 |
Bristol-Myers Squibb Company |
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
|
|
WO2002072549A1
(en)
|
2001-03-12 |
2002-09-19 |
Millennium Pharmaceuticals, Inc. |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
|
ES2278016T3
(es)
|
2001-04-09 |
2007-08-01 |
Novartis Vaccines And Diagnostics, Inc. |
Compuestos guanidino como agonistas del receptor de melanocortina 4 (mc4-r).
|
|
CN1527710A
(zh)
|
2001-05-14 |
2004-09-08 |
����˹�ж�-����˹˹����ҩƷ��˾ |
作为促肾上腺皮质激素释放因子配体的取代的吡嗪酮、吡啶和嘧啶
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
DE10143079A1
(de)
|
2001-09-03 |
2003-05-15 |
Zentaris Ag |
Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2003022214A2
(en)
|
2001-09-06 |
2003-03-20 |
Millennium Pharmaceuticals, Inc. |
Piperazine and homopiperazine compounds
|
|
JP2005508968A
(ja)
|
2001-10-19 |
2005-04-07 |
トランス テック ファーマ，インコーポレイテッド |
ＰＴＰ阻害剤としてのβ−カルボリン誘導体
|
|
DE10152306A1
(de)
|
2001-10-26 |
2003-07-24 |
Asta Medica Ag |
2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
|
|
TW200301251A
(en)
|
2001-12-20 |
2003-07-01 |
Wyeth Corp |
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
|
|
US20030236277A1
(en)
|
2002-02-14 |
2003-12-25 |
Kadow John F. |
Indole, azaindole and related heterocyclic pyrrolidine derivatives
|
|
WO2003080608A2
(en)
|
2002-03-27 |
2003-10-02 |
Glaxo Group Limited |
Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
|
|
WO2003087087A2
(en)
|
2002-04-09 |
2003-10-23 |
Astex Technology Limited |
Heterocyclic compounds and their use as modulators of p38 map kinase
|
|
US20040063744A1
(en)
|
2002-05-28 |
2004-04-01 |
Tao Wang |
Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
|
|
UA78999C2
(en)
|
2002-06-04 |
2007-05-10 |
Wyeth Corp |
1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
|
|
US6900206B2
(en)
|
2002-06-20 |
2005-05-31 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
|
|
TW200403243A
(en)
|
2002-07-18 |
2004-03-01 |
Wyeth Corp |
1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
DE60304718T2
(de)
|
2002-08-06 |
2007-04-26 |
Astrazeneca Ab |
Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
|
|
US20060247261A1
(en)
|
2002-08-21 |
2006-11-02 |
Eatherton Andrew J |
Pyrimidine compounds
|
|
GB0222493D0
(en)
|
2002-09-27 |
2002-11-06 |
Glaxo Group Ltd |
Compounds
|
|
EP1572097A4
(en)
|
2002-09-30 |
2010-02-17 |
Smithkline Beecham Corp |
NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF INFECTIONS WITH THE HEPATITIS C-VIRUS
|
|
FR2845388B1
(fr)
|
2002-10-08 |
2004-11-12 |
Sanofi Synthelabo |
Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
|
|
WO2004074286A1
(en)
|
2003-02-14 |
2004-09-02 |
Wyeth |
Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
|
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
|
KR20070034049A
(ko)
|
2004-06-09 |
2007-03-27 |
글락소 그룹 리미티드 |
피롤로피리딘 유도체
|